130 related articles for article (PubMed ID: 9415596)
21. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
Pham Q; Campbell R; Mattioni J; Sataloff R
J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
[TBL] [Abstract][Full Text] [Related]
22. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
23. Treatment of ventricular dysphonia with botulinum toxin.
Kendall KA; Leonard RJ
Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
[TBL] [Abstract][Full Text] [Related]
24. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.
Lundy DS; Lu FL; Casiano RR; Xue JW
J Voice; 1998 Dec; 12(4):460-6. PubMed ID: 9988033
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
Davidson BJ; Ludlow CL
Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
[TBL] [Abstract][Full Text] [Related]
28. A new paradigm for the management of essential vocal tremor with botulinum toxin.
Gurey LE; Sinclair CF; Blitzer A
Laryngoscope; 2013 Oct; 123(10):2497-501. PubMed ID: 23553653
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
30. A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor.
Estes C; Sadoughi B; Coleman R; Sarva H; Mauer E; Sulica L
Laryngoscope; 2018 Feb; 128(2):437-446. PubMed ID: 28988441
[TBL] [Abstract][Full Text] [Related]
31. Laryngeal dystonia: case report and treatment with botulinum toxin.
Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
[TBL] [Abstract][Full Text] [Related]
32. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
Adams SG; Hunt EJ; Charles DA; Lang AE
J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin injection to improve tracheoesophageal speech after total laryngectomy.
Zormeier MM; Meleca RJ; Simpson ML; Dworkin JP; Klein R; Gross M; Mathog RH
Otolaryngol Head Neck Surg; 1999 Mar; 120(3):314-9. PubMed ID: 10064631
[TBL] [Abstract][Full Text] [Related]
34. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
[TBL] [Abstract][Full Text] [Related]
35. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.
Bielamowicz S; Stager SV; Badillo A; Godlewski A
J Voice; 2002 Mar; 16(1):117-23. PubMed ID: 12002878
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
[TBL] [Abstract][Full Text] [Related]
37. Office-based laryngeal injection of botulinum toxin for paradoxical vocal fold motion in a child.
Montojo J; González R; Hernández E; Zafra M; Plaza G
Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1161-3. PubMed ID: 26032616
[TBL] [Abstract][Full Text] [Related]
38. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique.
Young N; Blitzer A
Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055
[TBL] [Abstract][Full Text] [Related]
39. Spasmodic Dysphonia.
Lin J; Sadoughi B
Adv Otorhinolaryngol; 2020; 85():133-143. PubMed ID: 33166970
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
Yin S; Stucker FJ; Nathan CO
J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]